General Information of Drug (ID: DMRML9B)

Drug Name
Isoxazoles and isoxazoline derivative 1 Drug Info
Synonyms PMID27172114-Compound-82
Cross-matching ID
TTD Drug ID
DMRML9B

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK065 DMO87YS Pancreatitis DC31-DC34 Phase 1 [2]
Isoxazoles and isoxazoline derivative 2 DMKCYSD N. A. N. A. Patented [1]
Aryl pyrimidine derivative 7 DM8FAW3 N. A. N. A. Patented [1]
Aryl pyrimidine derivative 2 DMU9Y4B N. A. N. A. Patented [1]
Cyclopropane 1-carboxylic acid derivative 6 DM0OMBW N. A. N. A. Patented [1]
PMID27172114-Compound-47 DMTIQYD N. A. N. A. Patented [1]
Isoxazoles and isoxazoline derivative 4 DMW3JZV N. A. N. A. Patented [1]
Cyclopropane 1-carboxylic acid derivative 2 DMSXB58 N. A. N. A. Patented [1]
Cyclopropane 1-carboxylic acid derivative 9 DMLH9AQ N. A. N. A. Patented [1]
Cyclopropane 1-carboxylic acid derivative 10 DM3M169 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Kynurenine 3-hydroxylase (KMO) TTIY56R KMO_HUMAN Inhibitor [1]

References

1 Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):815-32.
2 Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nat Commun. 2017 Jun 12;8:15827.